Kumar Sambamurti

Affiliations: 
Medical University of South Carolina, Charleston, SC, United States 
Area:
Neuroscience Biology
Google:
"Kumar Sambamurti"
Mean distance: 53433
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kindy MS, Akyol Ö, Sambamurti K. (2015) Preface. Turkish Journal of Medical Sciences. 45: i-ii
Baranello RJ, Bharani KL, Padmaraju V, et al. (2015) Amyloid-beta protein clearance and degradation (ABCD) pathways and their role in Alzheimer's disease. Current Alzheimer Research. 12: 32-46
Wang X, Zhu M, Hjorth E, et al. (2015) Resolution of inflammation is altered in Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 40-50.e1-2
Zhao Y, Bhattacharjee S, Jones BM, et al. (2014) Beta-Amyloid Precursor Protein (βAPP) Processing in Alzheimer's Disease (AD) and Age-Related Macular Degeneration (AMD). Molecular Neurobiology
Greig NH, Sambamurti K, Lahiri DK, et al. (2014) Amyloid-β precursor protein synthesis inhibitors for Alzheimer's disease treatment. Annals of Neurology. 76: 629-30
Barnwell E, Padmaraju V, Baranello R, et al. (2014) Evidence of a novel mechanism for partial γ-secretase inhibition induced paradoxical increase in secreted amyloid β protein. Plos One. 9: e91531
Greig NH, Tweedie D, Rachmany L, et al. (2014) Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injury. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: S62-75
Pinnix I, Ghiso JA, Pappolla MA, et al. (2013) Major carboxyl terminal fragments generated by γ-secretase processing of the Alzheimer amyloid precursor are 50 and 51 amino acids long. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 21: 474-83
Yu QS, Reale M, Kamal MA, et al. (2013) Synthesis of the Alzheimer drug Posiphen into its primary metabolic products (+)-N1-norPosiphen, (+)-N8-norPosiphen and (+)-N1, N8-bisnorPosiphen, their inhibition of amyloid precursor protein, α-Synuclein synthesis, interleukin-1β release, and cholinergic action. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry. 12: 117-28
Maloney B, Sambamurti K, Zawia N, et al. (2012) Applying epigenetics to Alzheimer's disease via the latent early-life associated regulation (LEARn) model. Current Alzheimer Research. 9: 589-99
See more...